Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction

by admin 0 Comments

Earnings
Share on Facebook
Share on Twitter
Share on Pinterest
Share on LinkedIn

The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%. 

Read the original report.

Share on Facebook
Share on Twitter
Share on Pinterest
Share on LinkedIn

Articles You May Like

Qualcomm stock drops 7% on weak earnings forecast as memory shortage weighs on smartphone sales
Stocks started the week with promise but ended in despair. Our take on the big reversal
The midterm election could reshape the muni bond market. Here’s what investors need to know
Figma sinks after earnings beat as company prioritizes long-term growth with AI changes
McDonald’s earnings beat, but traffic to its U.S. restaurants falls

Leave a Reply

Your email address will not be published. Required fields are marked *